bluebird bio, Inc. (BLUE)

$0.39 -3.63% $-0.01 Healthcare

bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell disease (SCD); and elivaldogene autotemcel to treat cerebral adrenoleukodystrophy. The company's clinical study program includes HGB-205, HGB-206, and HGB-210 to evaluate the safety and efficacy of lovo-cel in the treatment of patients with SCD; and HGB-204, HGB-205, HGB-207, and HGB-212 to evaluate the safety and efficacy of beti-cel in the treatment of patients with ß-thalassemia. It has strategic collaboration and license agreements with Orchard Therapeutics Limited, Forty Seven, Inc., and Magenta Therapeutics, Inc. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was incorporated in 1992 and is headquartered in Cambridge, Massachusetts.

$75.74M

Mr. Andrew Obenshain

518.00

Cambridge, MA

Jun 19, 2013

-0.17

$-2.30

0.48

0.68

-567.29%

-0.25

0.00

1.48

1.43

0.57

-57.13%

-207.25%

Similar stocks (7)

Madrigal Pharmaceuticals, Inc.

MDGL

$339.04 -0.18%
Neutral

Krystal Biotech, Inc.

KRYS

$187.22 -4.42%
Uptrend

PTC Therapeutics, Inc.

PTCT

$44.08 -1.76%
Uptrend

Agios Pharmaceuticals, Inc.

AGIO

$59.02 -2.38%
Uptrend

Mersana Therapeutics, Inc.

MRSN

$2.32 -8.30%
Downtrend

Karyopharm Therapeutics Inc.

KPTI

$0.90 -2.60%
Downtrend

Hepion Pharmaceuticals, Inc.

HEPA

$0.62 -6.44%
Downtrend

ETF Exposure (14)

Loncar Cancer Immunotherapy ETF

CNCR

3.28%

$15.09 -4.12%
Neutral

Invesco NASDAQ Future Gen 200 ETF

QQQS

0.34%

$28.74 -2.11%
Uptrend

Listed Funds Trust - Horizon Kinetics Medical ETF

MEDX

0.08%

$29.40 -0.54%
Downtrend

iShares Micro-Cap ETF

IWC

0.01737%

$135.90 -1.91%
Uptrend

iShares Biotechnology ETF

IBB

0.00708%

$144.36 -2.27%
Uptrend

Invesco Nasdaq Biotechnology ETF

IBBQ

0.007%

$23.77 -2.42%
Uptrend

iShares Russell 2000 Value ETF

IWN

0.00549%

$177.58 -1.76%
Uptrend

iShares Russell 2000 ETF

IWM

0.0027%

$237.36 -1.79%
Uptrend

ProShares Ultra Nasdaq Biotechnology

BIB

0.0022312776047842963%

$62.76 -5.40%
Uptrend

ProShares Hedge Replication ETF

HDG

4.186681061567723e-4%

$50.24 -0.58%
Uptrend

Dimensional U.S. Core Equity 2 ETF

DFAC

2.8459000000000004e-4%

$35.93 -0.53%
Uptrend

Dimensional U.S. Equity ETF

DFUS

4.1469999999999994e-5%

$65.17 -0.40%
Uptrend

iShares Russell 3000 ETF

IWV

4.0e-5%

$342.01 -0.45%
Uptrend

iShares Core S&P Total U.S. Stock Market ETF

ITOT

0%

$131.55 -0.45%
Uptrend